Carson Wealth (CWM LLC)
SNDX icon

Carson Wealth (CWM LLC)’s Syndax Pharmaceuticals SNDX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$865K Buy
37,046
+5,134
+16% +$112K ﹤0.01% 1635
2025
Q4 		$670K Buy
31,912
+10,737
+51% +$187K ﹤0.01% 1740
2025
Q3 		$326K Buy
21,175
+12,414
+142% +$162K ﹤0.01% 2063
2025
Q2 		$82K Sell
8,761
-14,613
-63% -$161K ﹤0.01% 2889
2025
Q1 		$287K Buy
23,374
+20,763
+795% +$293K ﹤0.01% 1697
2024
Q4 		$35K Buy
2,611
+855
+49% +$14.6K ﹤0.01% 3062
2024
Q3 		$34K Buy
1,756
+54
+3% +$1.12K ﹤0.01% 2999
2024
Q2 		$35K Sell
1,702
-22
-1% -$460 ﹤0.01% 2732
2024
Q1 		$41K Buy
1,724
+39
+2% +$870 ﹤0.01% 2433
2023
Q4 		$36K Buy
1,685
+1,358
+415% +$20.9K ﹤0.01% 2381
2023
Q3 		$5K Sell
327
-266
-45% -$5.03K ﹤0.01% 3492
2023
Q2 		$12K Buy
593
+586
+8,371% +$12.2K ﹤0.01% 2992
2023
Q1 		$0 Buy
+7
New +$174 ﹤0.01% 4325

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Carson Wealth (CWM LLC)'s SNDX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Syndax Pharmaceuticals (SNDX) stake by 16% in Q1 2026, buying an estimated $112K and bringing the position to 37,046 shares worth $865K. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

Carson Wealth (CWM LLC) first reported a position in SNDX in Q1 2023 and has held it in 13 quarters since. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 37,046 shares of Syndax Pharmaceuticals worth $865K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 5,134 Syndax Pharmaceuticals shares in Q1 2026, an estimated $112K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1635 holding.
  • Carson Wealth (CWM LLC) first reported a position in Syndax Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.